BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 290 filers reported holding BIONTECH SE in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,798 | -88.3% | 2,465 | -88.4% | 0.01% | -89.5% |
| Q2 2023 | $2,291,138 | +229113700.0% | 21,228 | +303157.1% | 0.08% | – |
| Q1 2023 | $1 | -99.6% | 7 | -99.5% | 0.00% | -100.0% |
| Q4 2022 | $227 | -99.9% | 1,510 | +7.5% | 0.01% | +200.0% |
| Q3 2022 | $190,000 | -88.7% | 1,405 | -87.5% | 0.00% | -92.1% |
| Q2 2022 | $1,682,000 | +56.8% | 11,277 | +79.3% | 0.04% | +280.0% |
| Q1 2022 | $1,073,000 | +69.2% | 6,289 | +155.7% | 0.01% | -9.1% |
| Q4 2021 | $634,000 | -55.2% | 2,460 | -52.5% | 0.01% | -69.4% |
| Q3 2021 | $1,415,000 | -58.3% | 5,182 | -65.8% | 0.04% | -59.1% |
| Q2 2021 | $3,390,000 | +5036.4% | 15,146 | +2391.1% | 0.09% | +8700.0% |
| Q1 2021 | $66,000 | -91.0% | 608 | -93.2% | 0.00% | -95.5% |
| Q4 2020 | $730,000 | +236.4% | 8,959 | +185.7% | 0.02% | +1000.0% |
| Q3 2020 | $217,000 | +3516.7% | 3,136 | +3236.2% | 0.00% | – |
| Q2 2020 | $6,000 | – | 94 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,038,674 | $85,000,000 | 19.42% |
| Artal Group S.A. | 1,000,000 | $81,520,000 | 1.75% |
| PARUS FINANCE (UK) Ltd | 49,210 | $4,012,000 | 1.17% |
| Ikarian Capital, LLC | 319,900 | $26,080,000 | 1.15% |
| Parametrica Management Ltd | 18,054 | $1,473,000 | 0.91% |
| ARMISTICE CAPITAL, LLC | 236,000 | $19,239,000 | 0.65% |
| SevenBridge Financial Group, LLC | 19,013 | $1,550,000 | 0.61% |
| Redmile Group, LLC | 580,746 | $47,342,000 | 0.57% |
| Redwood Investments, LLC | 82,246 | $6,705,000 | 0.57% |
| Paradigm Financial Advisors, LLC | 24,681 | $2,012,000 | 0.54% |